Background: Low serum testosterone level is associated with in-creased risk of type 2 diabetes (T2D) in overweight men with im-paired glucose tolerance (IGT). It is not known whether testosterone (T) treatment is effective and safe for preventing T2D in this high- risk group.Aim: To determine in a large, multicentre, double- blinded placebo- controlled RCT, whether T treatment combined with lifestyle inter-vention (Weight Watchers®) as compared to lifestyle intervention alone, reduces T2D at 2 years.
|Number of pages||2|
|Publication status||Published - Jun 2018|
Wittert, G., Atlantis, E., Grossmann, M., Yeap, B. B., Conway, A., Stuckey, B., Handelsman, D., McLachlan, R., Allan, C., Jenkins, A., Daniel, M., & Bracken, K. (2018). Testosterone for type 2 diabetes prevention in men: A 2-year multicentre, randomised, double-blind, placebo-controlled trial. Clinical Endocrinology, 89(S1), 47-48. https://onlinelibrary.wiley.com/doi/full/10.1111/cen.13727